ATE258176T1 - Neue azabicyclo derivate und ihre verwendung - Google Patents

Neue azabicyclo derivate und ihre verwendung

Info

Publication number
ATE258176T1
ATE258176T1 AT00901487T AT00901487T ATE258176T1 AT E258176 T1 ATE258176 T1 AT E258176T1 AT 00901487 T AT00901487 T AT 00901487T AT 00901487 T AT00901487 T AT 00901487T AT E258176 T1 ATE258176 T1 AT E258176T1
Authority
AT
Austria
Prior art keywords
derivatives
azabicyclo derivatives
new
new azabicyclo
labelled
Prior art date
Application number
AT00901487T
Other languages
English (en)
Inventor
Dan Peters
Joergen Scheel-Krueger
Elsebet Oestergaard Nielsen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of ATE258176T1 publication Critical patent/ATE258176T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00901487T 1999-01-28 2000-01-28 Neue azabicyclo derivate und ihre verwendung ATE258176T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900106 1999-01-28
DKPA199900950 1999-07-01
PCT/DK2000/000038 WO2000044746A1 (en) 1999-01-28 2000-01-28 Novel azabicyclo derivatives and their use

Publications (1)

Publication Number Publication Date
ATE258176T1 true ATE258176T1 (de) 2004-02-15

Family

ID=26063317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00901487T ATE258176T1 (de) 1999-01-28 2000-01-28 Neue azabicyclo derivate und ihre verwendung

Country Status (6)

Country Link
US (1) US6617459B2 (de)
EP (1) EP1149095B1 (de)
AT (1) ATE258176T1 (de)
AU (1) AU2278700A (de)
DE (1) DE60007841T2 (de)
WO (1) WO2000044746A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100398103C (zh) 2000-10-13 2008-07-02 神经研究公司 通过烟碱性受体激动剂和单胺能物质的联合作用治疗情感性精神障碍
US20030080191A1 (en) 2001-10-26 2003-05-01 Allen Lubow Method and apparatus for applying bar code information to products during production
WO2003052681A1 (en) 2001-12-17 2003-06-26 International Barcode Corporation Double-sided bar code doubling as a single bar code
WO2005121796A2 (en) * 2004-05-07 2005-12-22 The Regents Of The University Of California Method for detecting alzheimer’s disease and other forms of dementia, and measuring their progression
ATE462703T1 (de) 2004-08-25 2010-04-15 Actelion Pharmaceuticals Ltd Bicyclononen-derivate als renin-inhibitoren
MX2007007260A (es) * 2004-12-22 2007-08-14 Neurosearch As Nuevos derivados de azabiciclo sustituidos con naftilo y su uso como inhibidores de la recaptacion del neurotransmisor de monoamina.
EP1869034A1 (de) * 2005-04-08 2007-12-26 NeuroSearch A/S (+) - und (-) -8-alkyl-3-(trifluoralkylsulfonyloxy)-8-azabicyclo[3.2.1]oct-2-en
EP1728520A1 (de) * 2005-05-04 2006-12-06 Charité - Universitätsmedizin Berlin Verwendung von spezifisch an das Serotonin-Transport-Protein (SERT) bindenden Radiopharmaka zur Herstellung eines Diagnostikums zur Untersuchung von Kopfschmerzerkrankungen
WO2006117218A2 (en) * 2005-05-04 2006-11-09 Charite Universitätsmedizin - Berlin Serotonin-transport-protein binding radiopharmaceutical for the production of a diagnostic medicament for the diagnosis of headache
US8114382B2 (en) * 2006-12-11 2012-02-14 General Electric Company Myelin detection using benzofuran derivatives
WO2011025953A1 (en) * 2009-08-28 2011-03-03 Lexicor Medical Technology, Llc Systems and methods to identify a subgroup of adhd at higher risk for complicating conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509161A (en) * 1967-07-10 1970-04-28 Boehringer & Soehne Gmbh 3-phenyl-granatene-(2)-derivatives
GB9507203D0 (en) * 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
DE69637097T2 (de) * 1995-10-13 2007-09-20 Neurosearch A/S 8-Azabicyclo(3.2.1)Oct-2-en-Derivate, deren Herstellung und Anwendung
GB9706222D0 (en) * 1997-03-26 1997-05-14 Zeneca Ltd Bicyclic amine derivatives
KR100589872B1 (ko) * 1997-05-30 2006-06-15 뉴로서치 에이/에스 8-아자비사이클로(3,2,1)옥트-2-엔 유도체 및 이의 제조방법
WO1998054182A1 (en) * 1997-05-30 1998-12-03 Neurosearch A/S 9-AZABICYCLO(3.3.1)NON-2-ENE AND NONANE DERIVATIVES AS CHOLINERGIC LIGANDS AT NICOTINIC ACh RECEPTORS
JP2002501921A (ja) * 1998-01-28 2002-01-22 ニューロサーチ、アクティーゼルスカブ 標識された形での８−アザビシクロ［３．２．１］オクト−２−エン誘導体及び標識された及び標識されていない形での８−アザビシクロ［３．２．１］オクト−２−エン誘導体の使用方法

Also Published As

Publication number Publication date
DE60007841D1 (de) 2004-02-26
EP1149095B1 (de) 2004-01-21
WO2000044746A1 (en) 2000-08-03
US6617459B2 (en) 2003-09-09
AU2278700A (en) 2000-08-18
DE60007841T2 (de) 2004-07-08
EP1149095A1 (de) 2001-10-31
US20010047028A1 (en) 2001-11-29

Similar Documents

Publication Publication Date Title
CA2381819A1 (en) New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
DE60042066D1 (de) Chimärische dr4 antikörper und ihre verwendung
PT1053256E (pt) Anticorpos para o receptor de morte 4 (dr4) e utilizações destes
EA200200530A1 (ru) Гетероциклические замещенные пиразолоны
IL146631A0 (en) Diagnostics and therapeutics for cardiovascular disorders
DE60132017D1 (de) Neue benzazepine und ähnliche heterocyclische derivate,die als orexin rezeptor antagonisten geeignet sind
NO20022655D0 (no) &lt;Beta&gt;-2-adrenerge reseptoragonister
PL304496A1 (en) Novel tricyclic benzazepines, their transient compounds, pharmaceutical agents and methods of obtaining such compounds
YU20600A (sh) Nova upotreba antagonista 5-ht3 receptora
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
ATE258176T1 (de) Neue azabicyclo derivate und ihre verwendung
ATE359090T1 (de) Monoklonale antikörper spezifisch gegen vegf- rezeptoren und ihre verwendung
MXPA03009644A (es) Grupos azabiciclicos sustituidos para el tratamiento de enfermedades.
BG105445A (en) Phermaceutical agents for the treatment of parkinson&#39;s disease, adhd and microadenomas
MXPA04001089A (es) 5-arilsulfonil indoles que tienen afinidad por el receptor de 5-ht.
JO2207B1 (en) Pharmaceutical radiological compounds to diagnose Alzheimer&#39;s disease
IL147977A0 (en) Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
DE60038739D1 (de) Somatostatin analoge, deren radiomarkierte derivate und deren verwendung
MY133390A (en) Azabicyclic 5ht1 receptor ligands
CA2333086A1 (en) Cocaine receptor binding ligands
AU9363398A (en) Hepatitis c receptor protein cd81
PT1200400E (pt) Derivados de pirrolidino-2,3,4-trion-3-oxina substituidas com eficacia como antagonistas do receptor nmda
DE69428620D1 (de) Benzoxazule Derivate und ihre Anwendung als Serotonin 5HT3 Rezeptor Antagonisten
ATE453627T1 (de) Herstellung von verbindungen zur bestimmung der hypoxie
WO1999038866A8 (en) 8-azabicyclo[3.2.1]oct-2-ene derivatives in labelled form and use of 8-azabicyclo[3.2.1]oct-2-ene derivatives in labelled and unlabelled form

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties